Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 995
Single User License Price INR 70834
Corporate User License Price USD 2985
Corporate User License Price INR 212502
Site License Price USD 1990
Site License Price INR 141668
Request a Quote

Report Title

Generics Top 5 Emerging Markets Industry Guide 2017-2021

Quote Request for License Type
License Type Price  
Single User License USD 995
Site License USD 1990
Enterprise Wide License USD 2985
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Generics Top 5 Emerging Markets Industry Guide 2017-2021


Quote Request for License Type
License Type Price  
Single User License USD 995
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Generics Top 5 Emerging Markets Industry Guide 2017-2021

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Generics Top 5 Emerging Markets Industry Guide 2017-2021



Executive Summary

Generics Top 5 Emerging Markets Industry Guide 2017-2021

Summary

The Emerging 5 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the emerging five generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

These countries contributed USD80,985.8 million to the global generics industry in 2016, with a compound annual growth rate (CAGR) of 13.8% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of USD1,27,209.2 million in 2021, with a CAGR of 9.5% over the 2016-21 period.

Within the generics industry, China is the leading country among the top 5 emerging nations, with market revenues of USD57,010.8 million in 2016. This was followed by India and Mexico with a value of USD12,654.0 and USD5,430.1 million, respectively.

China is expected to lead the generics industry in the top five emerging nations, with a value of USD87,161.6 million in 2021, followed by India and Mexico with expected values of USD18,196.7 and USD10,769.6 million, respectively.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five generics market

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five generics market

Leading company profiles reveal details of key generics market players' emerging five operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the emerging five generics market with five year forecasts by both value and volume

Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country

Reasons to buy

What was the size of the emerging five generics market by value in 2016?

What will be the size of the emerging five generics market in 2021?

What factors are affecting the strength of competition in the emerging five generics market?

How has the market performed over the last five years?

How large is the emerging five generics market in relation to its regional counterparts?

Table of Contents

Introduction

What is this report about?

Who is the target reader?

How to use this report

Definitions

Top 5 Emerging Countries Generics

Industry Outlook

Generics in South Africa

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Brazil

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in China

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in India

Market Overview

Market Data

Market Segmentation 60

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Mexico

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Company Profiles

Leading Companies

Appendix

Methodology

About MarketLine

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Figure 1: Top 5 emerging countries generics industry, revenue (USDm), 2012-21

Figure 2: Top 5 emerging countries generics industry, revenue (USDm), 2012-16

Figure 3: Top 5 emerging countries generics industry forecast, revenue (USDm), 2016-21

Figure 4: South Africa generics market value: USD million, 2012-16

Figure 5: South Africa generics market volume: % of total pharma volume, 2012-16

Figure 6: South Africa generics market geography segmentation: % share, by value, 2016

Figure 7: South Africa generics market value forecast: USD million, 2016-21

Figure 8: South Africa generics market volume forecast: % of total pharma volume, 2016-21

Figure 9: Forces driving competition in the generics market in South Africa, 2016

Figure 10: Drivers of buyer power in the generics market in South Africa, 2016

Figure 11: Drivers of supplier power in the generics market in South Africa, 2016

Figure 12: Factors influencing the likelihood of new entrants in the generics market in South Africa, 2016

Figure 13: Factors influencing the threat of substitutes in the generics market in South Africa, 2016

Figure 14: Drivers of degree of rivalry in the generics market in South Africa, 2016

Figure 15: Brazil generics market value: USD million, 2012-16

Figure 16: Brazil generics market volume: % of total pharma volume, 2012-16

Figure 17: Brazil generics market geography segmentation: % share, by value, 2016

Figure 18: Brazil generics market value forecast: USD million, 2016-21

Figure 19: Brazil generics market volume forecast: % of total pharma volume, 2016-21

Figure 20: Forces driving competition in the generics market in Brazil, 2016

Figure 21: Drivers of buyer power in the generics market in Brazil, 2016

Figure 22: Drivers of supplier power in the generics market in Brazil, 2016

Figure 23: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2016

Figure 24: Factors influencing the threat of substitutes in the generics market in Brazil, 2016

Figure 25: Drivers of degree of rivalry in the generics market in Brazil, 2016

Figure 26: China generics market value: USD billion, 2012-16

Figure 27: China generics market volume: % of total pharma volume, 2012-16

Figure 28: China generics market geography segmentation: % share, by value, 2016

Figure 29: China generics market value forecast: USD billion, 2016-21

Figure 30: China generics market volume forecast: % of total pharma volume, 2016-21

Figure 31: Forces driving competition in the generics market in China, 2016

Figure 32: Drivers of buyer power in the generics market in China, 2016

Figure 33: Drivers of supplier power in the generics market in China, 2016

Figure 34: Factors influencing the likelihood of new entrants in the generics market in China, 2016

Figure 35: Factors influencing the threat of substitutes in the generics market in China, 2016

Figure 36: Drivers of degree of rivalry in the generics market in China, 2016

Figure 37: India generics market value: USD million, 2012-16

Figure 38: India generics market volume: % of total pharma volume, 2012-16

Figure 39: India generics market geography segmentation: % share, by value, 2016

Figure 40: India generics market value forecast: USD million, 2016-21

Figure 41: India generics market volume forecast: % of total pharma volume, 2016-21

Figure 42: Forces driving competition in the generics market in India, 2016

Figure 43: Drivers of buyer power in the generics market in India, 2016

Figure 44: Drivers of supplier power in the generics market in India, 2016

Figure 45: Factors influencing the likelihood of new entrants in the generics market in India, 2016

Figure 46: Factors influencing the threat of substitutes in the generics market in India, 2016

Figure 47: Drivers of degree of rivalry in the generics market in India, 2016

Figure 48: Mexico generics market value: USD million, 2012-16

Figure 49: Mexico generics market volume: % of total pharma volume, 2012-16

Figure 50: Mexico generics market geography segmentation: % share, by value, 2016

Figure 51: Mexico generics market value forecast: USD million, 2016-21

Figure 52: Mexico generics market volume forecast: % of total pharma volume, 2016-21

Figure 53: Forces driving competition in the generics market in Mexico, 2016

Figure 54: Drivers of buyer power in the generics market in Mexico, 2016

Figure 55: Drivers of supplier power in the generics market in Mexico, 2016

Figure 56: Factors influencing the likelihood of new entrants in the generics market in Mexico, 2016

Figure 57: Factors influencing the threat of substitutes in the generics market in Mexico, 2016

Figure 58: Drivers of degree of rivalry in the generics market in Mexico, 2016

Figure 59: Adcock Ingram Holdings Ltd: revenues & profitability

Figure 60: Adcock Ingram Holdings Ltd: assets & liabilities

Figure 61: Aspen Pharmacare Holdings Ltd: revenues & profitability

Figure 62: Aspen Pharmacare Holdings Ltd: assets & liabilities

Figure 63: Sanofi SA: revenues & profitability

Figure 64: Sanofi SA: assets & liabilities

Figure 65: China Grand Pharmaceutical and Healthcare Holdings Limited: revenues & profitability

Figure 66: China Grand Pharmaceutical and Healthcare Holdings Limited: assets & liabilities

Figure 67: Mylan N.V.: revenues & profitability

Figure 68: Mylan N.V.: assets & liabilities

Figure 69: Aurobindo Pharma Limited: revenues & profitability

Figure 70: Aurobindo Pharma Limited: assets & liabilities

Figure 71: Cipla Limited: revenues & profitability

Figure 72: Cipla Limited: assets & liabilities

Figure 73: Lupin Ltd: revenues & profitability

Figure 74: Lupin Ltd: assets & liabilities

Figure 75: Sun Pharmaceutical Industries Ltd: revenues & profitability

Figure 76: Sun Pharmaceutical Industries Ltd: assets & liabilities

Figure 77: Novartis AG: revenues & profitability

Figure 78: Novartis AG: assets & liabilities

Figure 79: Teva Pharmaceutical Industries Limited: revenues & profitability

Figure 80: Teva Pharmaceutical Industries Limited: assets & liabilities

List of Tables

Table 1: Top 5 emerging countries generics industry, revenue (USDm), 2012-21

Table 2: Top 5 emerging countries generics industry, revenue (USDm), 2012-16

Table 3: Top 5 emerging countries generics industry forecast, revenue (USDm), 2016-21

Table 4: South Africa generics market value: USD million, 2012-16

Table 5: South Africa generics market volume: % of total pharma volume, 2012-16

Table 6: South Africa generics market geography segmentation: USD million, 2016

Table 7: South Africa generics market value forecast: USD million, 2016-21

Table 8: South Africa generics market volume forecast: % of total pharma volume, 2016-21

Table 61: South Africa size of population (million), 2012-16

Table 62: South Africa gdp (constant 2005 prices, USD billion), 2012-16

Table 63: South Africa gdp (current prices, USD billion), 2012-16

Table 64: South Africa inflation, 2012-16

Table 65: South Africa consumer price index (absolute), 2012-16

Table 66: South Africa exchange rate, 2012-16

Table 9: Brazil generics market value: USD million, 2012-16

Table 10: Brazil generics market volume: % of total pharma volume, 2012-16

Table 11: Brazil generics market geography segmentation: USD million, 2016

Table 12: Brazil generics market value forecast: USD million, 2016-21

Table 13: Brazil generics market volume forecast: % of total pharma volume, 2016-21

Table 14: Brazil size of population (million), 2012-16

Table 15: Brazil gdp (constant 2005 prices, USD billion), 2012-16

Table 16: Brazil gdp (current prices, USD billion), 2012-16

Table 17: Brazil inflation, 2012-16

Table 18: Brazil consumer price index (absolute), 2012-16

Table 19: Brazil exchange rate, 2012-16

Table 20: China generics market value: USD billion, 2012-16

Table 21: China generics market volume: % of total pharma volume, 2012-16

Table 22: China generics market geography segmentation: USD billion, 2016

Table 23: China generics market value forecast: USD billion, 2016-21

Table 24: China generics market volume forecast: % of total pharma volume, 2016-21

Table 25: China size of population (million), 2012-16

Table 26: China gdp (constant 2005 prices, USD billion), 2012-16

Table 27: China gdp (current prices, USD billion), 2012-16

Table 28: China inflation, 2012-16

Table 29: China consumer price index (absolute), 2012-16

Table 30: China exchange rate, 2012-16

Table 31: India generics market value: USD million, 2012-16

Table 32: India generics market volume: % of total pharma volume, 2012-16

Table 33: India generics market geography segmentation: USD million, 2016

Table 34: India generics market value forecast: USD million, 2016-21

Table 35: India generics market volume forecast: % of total pharma volume, 2016-21

Table 36: India size of population (million), 2012-16

Table 37: India gdp (constant 2005 prices, USD billion), 2012-16

Table 38: India gdp (current prices, USD billion), 2012-16

Table 39: India inflation, 2012-16

Table 40: India consumer price index (absolute), 2012-16

Table 41: India exchange rate, 2012-16

Table 42: Mexico generics market value: USD million, 2012-16

Table 43: Mexico generics market volume: % of total pharma volume, 2012-16

Table 44: Mexico generics market geography segmentation: USD million, 2016

Table 45: Mexico generics market value forecast: USD million, 2016-21

Table 46: Mexico generics market volume forecast: % of total pharma volume, 2016-21

Table 47: Mexico size of population (million), 2012-16

Table 48: Mexico gdp (constant 2005 prices, USD billion), 2012-16

Table 49: Mexico gdp (current prices, USD billion), 2012-16

Table 50: Mexico inflation, 2012-16

Table 51: Mexico consumer price index (absolute), 2012-16

Table 52: Mexico exchange rate, 2012-16

Table 53: Adcock Ingram Holdings Ltd: key facts

Table 54: Adcock Ingram Holdings Ltd: key financials (USD)

Table 55: Adcock Ingram Holdings Ltd: key financials (ZAR)

Table 56: Adcock Ingram Holdings Ltd: key financial ratios

Table 57: Aspen Pharmacare Holdings Ltd: key facts

Table 58: Aspen Pharmacare Holdings Ltd: key financials (USD)

Table 59: Aspen Pharmacare Holdings Ltd: key financials (ZAR)

Table 60: Aspen Pharmacare Holdings Ltd: key financial ratios

Table 67: Ache Laboratorios Farmaceuticos SA: key facts

Table 68: EMS SA: key facts

Table 69: Sanofi SA: key facts

Table 70: Sanofi SA: key financials (USD)

Table 71: Sanofi SA: key financials (�)

Table 72: Sanofi SA: key financial ratios

Table 73: Eurofarma Laboratorios SA: key facts

Table 74: China Grand Pharmaceutical and Healthcare Holdings Limited: key facts

Table 75: China Grand Pharmaceutical and Healthcare Holdings Limited: key financials (USD)

Table 76: China Grand Pharmaceutical and Healthcare Holdings Limited: key financials (CNY)

Table 77: China Grand Pharmaceutical and Healthcare Holdings Limited: key financial ratios

Table 78: Mylan N.V.: key facts

Table 79: Mylan N.V.: key financials (USD)

Table 80: Mylan N.V.: key financial ratios

Table 81: Aurobindo Pharma Limited: key facts

Table 82: Aurobindo Pharma Limited: key financials (USD)

Table 83: Aurobindo Pharma Limited: key financials (AUSD)

Table 84: Aurobindo Pharma Limited: key financial ratios

Table 85: Cipla Limited: key facts

Table 86: Cipla Limited: key financials (USD)

Table 87: Cipla Limited: key financials (Rs.)

Table 88: Cipla Limited: key financial ratios

Table 89: Lupin Ltd: key facts

Table 90: Lupin Ltd: key financials (USD)

Table 91: Lupin Ltd: key financials (Rs.)

Table 92: Lupin Ltd: key financial ratios

Table 93: Sun Pharmaceutical Industries Ltd: key facts

Table 94: Sun Pharmaceutical Industries Ltd: key financials (USD)

Table 95: Sun Pharmaceutical Industries Ltd: key financials (Rs.)

Table 96: Sun Pharmaceutical Industries Ltd: key financial ratios

Table 97: Apotex, Inc.: key facts

Table 98: Novartis AG: key facts

Table 99: Novartis AG: key financials (USD)

Table 100: Novartis AG: key financial ratios

Table 101: Teva Pharmaceutical Industries Limited: key facts

Table 102: Teva Pharmaceutical Industries Limited: key financials (USD)

Table 103: Teva Pharmaceutical Industries Limited: key financial ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person